(19)
(11) EP 1 511 473 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.07.2013 Bulletin 2013/30

(45) Mention of the grant of the patent:
17.04.2013 Bulletin 2013/16

(21) Application number: 03730117.3

(22) Date of filing: 26.05.2003
(51) International Patent Classification (IPC): 
C07C 215/28(2006.01)
C07C 217/54(2006.01)
C07C 251/48(2006.01)
C07C 255/43(2006.01)
C07C 311/08(2006.01)
C07D 317/58(2006.01)
C07F 9/09(2006.01)
C07D 333/20(2006.01)
 C07C 215/46(2006.01)
C07C 237/30(2006.01)
C07C 255/13(2006.01)
C07C 255/58(2006.01)
C07D 261/08(2006.01)
C07C 333/20(2006.01)
C07D 263/57(2006.01)
(86) International application number:
PCT/EP2003/005510
(87) International publication number:
WO 2003/099192 (04.12.2003 Gazette 2003/49)

(54)

BIS-AROMATIC ALKANOLS

BIS-AROMATISCHE ALKANOLE

ALCANOLS BI-AROMATIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 27.05.2002 GB 0212210
14.11.2002 GB 0226624
10.12.2002 US 432704 P

(43) Date of publication of application:
09.03.2005 Bulletin 2005/10

(73) Proprietors:
  • Novartis AG
    4056 Basel (CH)
    Designated Contracting States:
    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 
  • IRM LLC
    Hamilton HM LX (BM)

(72) Inventors:
  • FAN, Yi
    San Diego, CA 92129 (US)
  • GAO, Wenqi
    San Diego, CA 92127 (US)
  • GRAY, Nathanael, S.
    Boston, MA 02130 (US)
  • HINTERDING, Klaus
    79599 Wittlingen (DE)
  • LEFEBVRE, Sophie
    34090 Montpellier (FR)
  • MI, Yuan
    Shanghai, 200010 (CN)
  • NUSSBAUMER, Peter
    44227 Dortmund (DE)
  • PAN, Shifeng
    San Diego, CA 92121 (US)
  • WANG, Wei
    Albuquerque, New Mexico 87122 (US)
  • ZECRI, Frédéric
    Brookline, MA 02446 (US)
  • PEREZ, Lawrence, Blas
    Hopkinton, MA 01748 (US)
  • LA MONTAGNE, Kenneth, Richard
    Morristown, NJ 07960 (US)
  • ETTMAYER, Peter
    A-1230 Wien (AT)

(74) Representative: Maucher, Wolfgang et al
Patent- und Rechtsanwaltssozietät Maucher, Börjes & Kollegen Urachstrasse 23
79102 Freiburg im Breisgau
79102 Freiburg im Breisgau (DE)


(56) References cited: : 
EP-A- 0 627 406
 EP-A- 0 778 263
   
  • ADACHI K ET AL: "Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 5, no. 8, 20 April 1995 (1995-04-20), pages 853-856, XP004135557 ISSN: 0960-894X
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).